Chronic Cluster Headache
20
2
3
12
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
5.0%
1 terminated out of 20 trials
92.3%
+5.8% vs benchmark
30%
6 trials in Phase 3/4
42%
5 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (20)
REsponse to Combined SONS and ONS in Chronic Cluster headachE
Response to Combined Trigeminal and Occipital Nerve Stimulation for the Preventive Treatment in Chronic Cluster Headache
Efficacy, Safety and Tolerability of Low Sodium Oxybate for Nocturnal Cluster Headache Attacks
LSD to Improve Cluster Headache Impact Trial
Treatment of Chronic Cluster Headache with TENS and ONS
A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH)
Bilateral Occipital Nerve Field Stimulation for the Treatment of dtCCH
A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache
A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)
A Study of Galcanezumab in Participants With Chronic Cluster Headache
Occipital Nerve Stimulation in Medically Intractable Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
SPG Neurostimulation in Cluster Patients
Efficacy of Modified Atkins Ketogenic Diet in Chronic Cluster Headache: a Prospective Case Series
Pathway CH-1 Long-Term Follow-Up
Anodal Transcranial Direct Stimulation (tDCS) for the Treatment of Chronic Cluster Headache
Prevention and Acute Treatment of Chronic Cluster Headache Compared to Standard of Care
Sphenopalatine Ganglion Stimulation for the Acute Treatment of Cluster Headache
Cephalic Vascular Recording Upon SPG Stimulation
Sumatriptan 4 mg Statdose in the Acute Treatment of Cluster Headache